International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update.

ABSTRACT:

Objective

To update the 2016 formal consensus-based guidance for the management of myasthenia gravis (MG) based on the latest evidence in the literature.

Methods

In October 2013, the Myasthenia Gravis Foundation of America appointed a Task Force to develop treatment guidance for MG, and a panel of 15 international experts was convened. The RAND/UCLA appropriateness method was used to develop consensus recommendations pertaining to 7 treatment topics. In February 2019, the international panel was reconvened with the addition of one member to represent South America. All previous recommendations were reviewed for currency, and new consensus recommendations were developed on topics that required inclusion or updates based on the recent literature. Up to 3 rounds of anonymous e-

SUBMITTER: Narayanaswami P 

PROVIDER: S-EPMC7884987 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature